Fidelity Advisor Biotechnology Fund
Fidelity Advisor Biotechnology Fund (FBTTX) Revenue
Annual & quarterly revenue history · segment & region breakdown
FBTTX · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsFidelity Advisor Biotechnology Fund trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Asset ManagementCompare FBTTX revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Fidelity Advisor Biotechnology Fund receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Fidelity Advisor Biotechnology Fund reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Fidelity Advisor Biotechnology Fund's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
FBTTX revenue · 4 questionsFBTTX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Fidelity Advisor Biotechnology Fund SEC filings · GAAP · Fidelity Advisor Biotechnology Fund SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026